About the Event
The promise of using pluripotent stem cells to treat people who may otherwise live the rest of their lives with incurable disease is starting to be realized. But as with any new technology, the applications are limited, and cost is a barrier to widespread adoption of the treatments.
LizarBio has developed a new method for creating tissue-authentic cells with high regenerative potential for a fraction of the cost of current technology. This allows them to cultivate and differentiate cells at industrial scale which will unlock the promise of the regenerative medicine by making curative therapies available to hundreds of thousands of patients per year.
Join our webinar to hear LizarBio CEO, Marcos Valadares share the details of their innovative process, how it significantly reduces costs and speeds pluripotent cell development, and the ongoing programs to treat heart disease and Rhett Syndrome.